Skip to content

HEERSE APOTHEEK: what changed

BE 0466.404.110NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€43,591
2024 · €90,269-€46,679
Equity
€151,534
2024 · €151,443+€91
Cash
€166,351
2024 · €239,512-€73,161
Balance sheet total
€1.6m
2024 · €1.6m-€61,372

Largest movements

2024 to 2025
Assets
  • Current investments +€100,000

    first reported in 2025, at €100,000

  • Cash -€73,161

    down €73,161 (-30.5%), from €239,512 to €166,351

    mainly Current investments (-€100,000) and Debts after one year (-€64,746)

  • Tangible fixed assets -€58,541

    down €58,541 (-6.3%), from €928,228 to €869,688

    of which Land and buildings: -€46,440

  • Receivables within one year -€35,779

    down €35,779 (-14.0%), from €254,920 to €219,141

    of which Trade receivables: -€39,993

Equity and liabilities
  • Debts after one year -€64,746

    down €64,746 (-9.7%), from €667,582 to €602,836

  • Other debts +€41,343

    up €41,343 (+8.8%), from €471,011 to €512,354

  • Accrued charges and deferred income -€17,519

    down €17,519 (-71.2%), from €24,589 to €7,069

Income statement
  • Staff costs +€36,786

    up €36,786 (+19.9%), from €184,871 to €221,657

  • Gross operating margin -€20,271

    down €20,271 (-5.5%), from €370,156 to €349,886

  • Taxes -€12,041

    down €12,041 (-60.5%), from €19,890 to €7,849

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €90,269
Gross operating margin -€20,271
Staff costs -€36,786
Depreciation -€947
Other operating charges +€874
Other operating items -€2,696
Financial income -€768
Financial charges +€1,874
Taxes +€12,041
Result 2025 €43,591
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€150,322
Investment -€100,000
Financing -€123,484
Cash 2024 €239,512
Net result for the year +€43,591
Depreciation +€58,541
Stocks and contracts -€11,206
Receivables within one year +€35,779
Deferred charges and accrued income +€5,097
Trade debts -€7,979
Tax, wage and social debts +€2,676
Other debts +€41,343
Accrued charges and deferred income -€17,519
Current investments -€100,000
Debts after one year -€64,746
Current portion of long-term debt -€15,238
Contributions, distributions and other -€43,500
Cash 2025 €166,351
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,634,683 €1,573,311 -€61,372 -3.8%
Fixed assets 21/28 €943,975 €885,434 -€58,541 -6.2%
Tangible fixed assets 22/27 €928,228 €869,688 -€58,541 -6.3%
Land and buildings 22 €877,642 €831,203 -€46,440 -5.3%
Plant, machinery and equipment 23 €42,748 €33,236 -€9,512 -22.3%
Furniture and vehicles 24 €7,838 €5,249 -€2,589 -33.0%
Financial fixed assets 28 €15,747 €15,747 = 0.0%
Current assets 29/58 €690,708 €687,877 -€2,831 -0.4%
Stocks and contracts in progress 3 €181,896 €193,103 +€11,206 +6.2%
Stocks 30/36 €181,896 €193,103 +€11,206 +6.2%
Amounts receivable within one year 40/41 €254,920 €219,141 -€35,779 -14.0%
Trade receivables 40 €254,538 €214,545 -€39,993 -15.7%
Other amounts receivable 41 €382 €4,596 +€4,214 +1,102%
Current investments 50/53 - €100,000 +€100,000
Cash at bank and in hand 54/58 €239,512 €166,351 -€73,161 -30.5%
Deferred charges and accrued income 490/1 €14,379 €9,282 -€5,097 -35.4%
Total equity and liabilities 10/49 €1,634,683 €1,573,311 -€61,372 -3.8%
Equity 10/15 €151,443 €151,534 +€91 +0.1%
Contributions 10/11 €7,000 €7,000 = 0.0%
Reserves 13 €144,443 €144,534 +€91 +0.1%
Distributable reserves 133 €144,443 €144,534 +€91 +0.1%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €1,483,240 €1,421,777 -€61,463 -4.1%
Amounts payable after more than one year 17 €667,582 €602,836 -€64,746 -9.7%
Financial debts 170/4 €667,582 €602,836 -€64,746 -9.7%
Amounts payable within one year 42/48 €791,070 €811,872 +€20,803 +2.6%
Current portion of amounts payable after more than one year 42 €79,984 €64,746 -€15,238 -19.1%
Trade debts 44 €159,138 €151,160 -€7,979 -5.0%
Suppliers 440/4 €159,138 €151,160 -€7,979 -5.0%
Taxes, remuneration and social security 45 €80,937 €83,612 +€2,676 +3.3%
Taxes 450/3 €32,957 €33,615 +€659 +2.0%
Remuneration and social security 454/9 €47,980 €49,997 +€2,017 +4.2%
Other amounts payable 47/48 €471,011 €512,354 +€41,343 +8.8%
Accrued charges and deferred income 492/3 €24,589 €7,069 -€17,519 -71.2%
Non-recurring operating income 76A €0 - =
Remuneration, social security and pensions 62 €184,871 €221,657 +€36,786 +19.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €57,594 €58,541 +€947 +1.6%
Other operating charges 640/8 €3,213 €2,339 -€874 -27.2%
Non-recurring operating charges 66A €65 €2,761 +€2,696 +4,171%
Gross operating margin 9900 €370,156 €349,886 -€20,271 -5.5%
Operating profit (loss) 9901 €124,413 €64,587 -€59,826 -48.1%
Financial income 75/76B €2,397 €1,629 -€768 -32.0%
Recurring financial income 75 €2,397 €1,629 -€768 -32.0%
Financial charges 65/66B €16,650 €14,776 -€1,874 -11.3%
Recurring financial charges 65 €16,650 €14,776 -€1,874 -11.3%
Profit (loss) for the period before taxes 9903 €110,160 €51,440 -€58,720 -53.3%
Income taxes 67/77 €19,890 €7,849 -€12,041 -60.5%
Profit (loss) for the period 9904 €90,269 €43,591 -€46,679 -51.7%
Profit (loss) for the period to be appropriated 9905 €90,269 €43,591 -€46,679 -51.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€364,824 to €480,447

Midpoint €413,000 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €151,534
Capitalised earnings €578,114 to €809,360
Indication €364,824 to €480,447

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€151,534
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€151,534

Capitalised earnings

net result for the year (9904)
2025
€43,591
excluding non-recurring income and charges
€46,352
2024
€90,269
excluding non-recurring income and charges
€90,334
2023
€108,897
excluding non-recurring income and charges
€106,121
2022
€218,705
excluding non-recurring income and charges
€46,015
2021
€12,487
Average result, excluding non-recurring income and charges
€80,936
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€578,114 / €674,467 / €809,360

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.